Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GKT136901 hydrochloride is a powerful, selective, and orally active inhibitor of NADPH oxidase (NOX1/4). It exhibits K i values of 160 nM and 165 nM against NOX1 and NOX4, respectively. Additionally, GKT136901 hydrochloride demonstrates selectivity and direct scavenging ability towards peroxynitrite. This compound finds utility in studying diabetic nephropathy, stroke, neurodegeneration, and possesses anti-inflammatory properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | $ 39.00 | |
10 mg | 5 days | $ 73.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 45.00 |
Description | GKT136901 hydrochloride is a powerful, selective, and orally active inhibitor of NADPH oxidase (NOX1/4). It exhibits K i values of 160 nM and 165 nM against NOX1 and NOX4, respectively. Additionally, GKT136901 hydrochloride demonstrates selectivity and direct scavenging ability towards peroxynitrite. This compound finds utility in studying diabetic nephropathy, stroke, neurodegeneration, and possesses anti-inflammatory properties. |
In vitro | GKT136901 (10 μM; 30 min) effectively reduces the increase in O2?? production and H2O2 generation in MPT cells caused by high-D-glucose[4]. It also eliminates high D-glucose's effect on p38MAP kinase activation in MPT cells[4]. Additionally, when applied for 2 hours, GKT136901 (10 μM) mitigates methamphetamine (METH)-induced oxidative stress and protects against METH-induced blood-brain barrier (BBB) dysfunction in HBMECs[5]. |
In vivo | GKT136901, administered orally at doses of 30-90 mg/kg daily for 16 weeks, exhibits renoprotective effects in a male db/db and db/m mouse model of Type 2 diabetes. This regimen notably reduces albuminuria, thiobarbituric acid-reacting substances (TBARS), and renal ERK1/2 phosphorylation, while preserving the renal structure in diabetic mice. It does not, however, affect plasma glucose levels, blood pressure (BP), or body weight. |
Synonyms | GKT136901 hydrochloride |
Molecular Weight | 403.26 |
Formula | C19H16Cl2N4O2 |
CAS No. | 1254507-01-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GKT136901 hydrochloride 1254507-01-1 GKT-136901 Hydrochloride GKT136901 Hydrochloride GKT-136901 hydrochloride GKT 136901 Hydrochloride inhibitor inhibit